Of those miRNAs, hsa-miR-185-5p targeted both genes BCAS4 and SHISA7. The hsa-miR-185-5p expression levels in TC samples of AD were statistically higher than those in controls (log2FC = 0.37, adj.P.Val = 7.89E-24). This evidence concerns the gene BCAS4 and Alzheimer disease.